ATE427755T1 - Verwendung von lh fur die kontrollierte ovarielle hyperstimulation - Google Patents

Verwendung von lh fur die kontrollierte ovarielle hyperstimulation

Info

Publication number
ATE427755T1
ATE427755T1 AT02767637T AT02767637T ATE427755T1 AT E427755 T1 ATE427755 T1 AT E427755T1 AT 02767637 T AT02767637 T AT 02767637T AT 02767637 T AT02767637 T AT 02767637T AT E427755 T1 ATE427755 T1 AT E427755T1
Authority
AT
Austria
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Application number
AT02767637T
Other languages
English (en)
Inventor
Stephen Hillier
Colin Howles
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE427755(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE427755T1 publication Critical patent/ATE427755T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02767637T 2001-09-12 2002-09-12 Verwendung von lh fur die kontrollierte ovarielle hyperstimulation ATE427755T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12

Publications (1)

Publication Number Publication Date
ATE427755T1 true ATE427755T1 (de) 2009-04-15

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02767637T ATE427755T1 (de) 2001-09-12 2002-09-12 Verwendung von lh fur die kontrollierte ovarielle hyperstimulation

Country Status (27)

Country Link
US (1) US7341989B2 (de)
EP (1) EP1434600B1 (de)
JP (1) JP2005504072A (de)
KR (1) KR20040032953A (de)
CN (1) CN1302806C (de)
AR (1) AR036591A1 (de)
AT (1) ATE427755T1 (de)
AU (1) AU2002331939B2 (de)
BR (1) BR0212502A (de)
CA (1) CA2457067A1 (de)
CY (1) CY1110487T1 (de)
DE (1) DE60231892D1 (de)
DK (1) DK1434600T3 (de)
EA (1) EA009210B1 (de)
ES (1) ES2322136T3 (de)
HR (1) HRP20040070A2 (de)
IL (1) IL160781A0 (de)
ME (1) MEP38808A (de)
MX (1) MXPA04002125A (de)
NO (1) NO327154B1 (de)
PL (1) PL205472B1 (de)
PT (1) PT1434600E (de)
RS (1) RS51505B (de)
SI (1) SI1434600T1 (de)
UA (1) UA78970C2 (de)
WO (1) WO2003022301A2 (de)
ZA (1) ZA200401008B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1684737A (zh) * 2002-06-07 2005-10-19 阿雷斯贸易股份有限公司 控制性超排卵方法及该方法使用的药物试剂盒
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
CA2372714A1 (en) * 1999-05-07 2000-11-16 Stephen Franks The use of luteinizing hormone in the induction of pauci-or unifolliculogenesis

Also Published As

Publication number Publication date
KR20040032953A (ko) 2004-04-17
PL205472B1 (pl) 2010-04-30
AU2002331939B2 (en) 2007-10-25
YU21204A (sh) 2006-08-17
WO2003022301A2 (en) 2003-03-20
DK1434600T3 (da) 2009-05-25
WO2003022301A3 (en) 2003-04-17
HRP20040070A2 (en) 2004-10-31
US7341989B2 (en) 2008-03-11
JP2005504072A (ja) 2005-02-10
IL160781A0 (en) 2004-08-31
PL367343A1 (en) 2005-02-21
ZA200401008B (en) 2005-08-31
ES2322136T3 (es) 2009-06-17
EA009210B1 (ru) 2007-12-28
CN1553809A (zh) 2004-12-08
HK1067866A1 (en) 2005-04-22
AR036591A1 (es) 2004-09-22
MXPA04002125A (es) 2004-07-08
EP1434600A2 (de) 2004-07-07
SI1434600T1 (sl) 2009-06-30
CA2457067A1 (en) 2003-03-20
RS51505B (sr) 2011-06-30
CN1302806C (zh) 2007-03-07
MEP38808A (en) 2011-02-10
BR0212502A (pt) 2004-08-24
UA78970C2 (uk) 2007-05-10
CY1110487T1 (el) 2015-04-29
US20050049199A1 (en) 2005-03-03
EP1434600B1 (de) 2009-04-08
DE60231892D1 (de) 2009-05-20
NO327154B1 (no) 2009-05-04
PT1434600E (pt) 2009-04-28
NO20040990L (no) 2004-03-08
EA200400428A1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
EP1514436A4 (de) Zweischwellen-aufwärtsstreckenratensteuerung zur ermöglichung von aufwärtsstrecken-einteilung
DE50209426D1 (de) Verarbeitung von Acrylat-Hotmelts mittels reaktiver Extrusion
DE60225081D1 (de) Herstellungsverfahren von Esterwachs
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
NO20044112L (no) Fremgangsmate ved induksjon av terminal differensiering
DE60329521D1 (de) Koordinierung von mehrschichtiger prozesssteuerung und optimierungsverfahren
DE02784674T1 (de) Quantifizierung von polypeptiden
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
NO20033679D0 (no) Nye pyrimidinforbindelser
PT1401828E (pt) Compostos de n-formil-hidroxilamina como inibidores de pdf
ATE372118T1 (de) Die verwendung von rosiglitazon zur behandlung von psychiatrischen erkrankungen.
DE10295497D2 (de) Vernetzung von Photoinitiator-initialisierten Polyacrylaten
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
DE60231892D1 (de) Verwendung von lh für die kontrollierte ovarielle hyperstimulation
DE50311406D1 (de) Verwendung von Formkörpern
DE50202698D1 (de) Beschichtungsverfahren
EP1389456A4 (de) Kosmetisches operationsverfahren
DE60232935D1 (de) Herstellungsverfahren von Druckeinheiten
DE60234626D1 (de) Düse zum extrusionsformen von wabenkörpern
ATE349556T1 (de) Verwendung von copolymerisaten als hilfsmittel für die lederherstellung
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
DE60131682D1 (de) Biologische bekämpfung von pflanzenkrankheiten
FR2843883B1 (fr) Extraits de sangsues pour psoriasis
FI20010482L (fi) Menetelmä kuitumassan laadun ohjaamiseksi
DE50203046D1 (de) Verwendung von Esterquats

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1434600

Country of ref document: EP

EEFA Change of the company name